Blood markers in acne severity
Part of Skin clinical trials.
This study measures two substances in the blood (CXCL10 and CRP) to see if they relate to acne severity. It may help understand inflammation in acne and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 12 and 40 years old.
- You have been diagnosed with acne vulgaris (common acne).
- Your acne is mild, moderate, or severe (any level of acne qualifies).
- You are not currently taking any oral acne medications like isotretinoin or antibiotics, or anti-inflammatory drugs.
- You do not have autoimmune diseases, other chronic inflammatory conditions, or an active infection.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the link between acne and cholesterol levels in young adults. It enrolls healthy volunteers who have never had acne and aren't taking any medications to see if there is a connection.
This study is comparing levels of certain fats (ceramides) in the blood of people with acne versus healthy volunteers. Researchers want to see if these fats are linked to acne severity, which could lead to better treatments.
This study tests whether balancing the bacteria on your skin can help treat mild to moderate acne. Researchers will take facial photos and follow your progress to see if this new approach works.
This trial measures a blood protein called catestatin in people with moderate to severe acne. It aims to understand how catestatin relates to acne, which may help guide future treatments.
This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
Hear when a new Acne Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.